|Articles|December 3, 2012

AHIP's Fall Forum 2012 Slideshow

Check out photos from America's Health Insurance Plans Fall Forum 2012. The meeting is being held at the Renaissance Hotel in Chicago, IL, from December 3-5.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Debates at the International Stroke Conference 2026 centered on optimal treatment of ischemic stroke in the modern era. | Image credit: Aliaksandr Marko - stock.adobe.com

Is Less More After Thrombolysis? Debating Intensive Stroke Monitoring at ISC 2026

ByRose McNulty

February 6th 2026

The OCEANIC-STROKE subgroup analysis findings, in tandem with the main results presented at ISC 2026, suggest that targeting factor XIa could be a safe way to intensify antithrombotic therapy following noncardioembolic stroke, regardless of underlying etiology. | Image credit: jolygon - stock.adobe.com

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

ByRose McNulty

February 6th 2026

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

BySkylar Jeremias,Luke Messac, MD, PhD

February 6th 2026

GLP-1 agonists remain largely untested in this at-risk patient population and warrant further research, experts said. | Image credit: mingnimit - stock.adobe.com

How Do GLP-1 Agonists Fit Into Stroke Care?

ByRose McNulty

February 6th 2026

Understanding Real-World MRI Utilization for ED Dizziness: Ava L. Liberman, MD

BySkylar Jeremias

February 5th 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

AHIP's Fall Forum 2012 Slideshow

Newsletter

Related Content

Is Less More After Thrombolysis? Debating Intensive Stroke Monitoring at ISC 2026

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

How Do GLP-1 Agonists Fit Into Stroke Care?

Understanding Real-World MRI Utilization for ED Dizziness: Ava L. Liberman, MD

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making

5 Things to Know About the Oral GLP-1 Era